Wavefront analysis based on ablation parameters

US10980439B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10980439-B2
Application numberUS-201414452675-A
CountryUS
Kind codeB2
Filing dateAug 6, 2014
Priority dateAug 6, 2014
Publication dateApr 20, 2021
Grant dateApr 20, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method, including recording parameters indicative of a quality of ablation performed at one or more sites in a region of a human heart, and receiving a set of electrophysiological signals indicative of a wave of electrical activation flowing through the region. The method further includes identifying locations within the region at which the wave is blocked from flowing and estimating confidence levels with respect to a blockage of the wave at the locations in response to the signals and the parameters. The method also includes displaying a map of the human heart including an indication of the confidence levels.

First claim

Opening claim text (preview).

We claim: 1. A computer implemented method, comprising: before an ablation step, recording a first set of electrophysiological signals at a plurality of first locations in a region of a human heart; during an ablation step, recording parameters indicative of a quality of ablation performed at one or more ablation sites in the region of the human heart; after the ablation step, recording a second set of electrophysiological signals indicative of a wave of electrical activation flowing through the region at a plurality of second locations in the region of the human heart; identifying from a comparison of the first set of electrophysiological signals and the second set of electrophysiological signals a plurality of blocking locations within the region at which the wave is blocked from flowing by the ablation during the ablation step; for each identified blocking location of the plurality of blocking locations within the region of the heart: estimating a first confidence level with respect to a blockage of the wave at the identified blocking location by comparing an electrophysiological signal from the second set of the electrophysiological signals with an electrophysiological signal of the first set of the electrophysiological signals, where the electrophysiological signals from the first set of electrophysiological signals and the second sets of electrophysiological signals are recorded over a plurality of heart beats in proximity to the identified blocking location; estimating a second confidence level with respect to the blockage of the wave at the identified blocking location in response to the recorded parameters indicative of a quality of ablation; and determining an overall confidence level for each blocking location by combining the first confidence level and the second confidence level, the overall confidence level being an overall measure of the quality of the wave blocking and the ablation of the identified blocking location; displaying a map of the human heart including an identified blocking location and an indication of the overall confidence level of that blocking location; and wherein the first set of electrophysiological signals and the second set of electrophysiological signals are unstimulated electrophysiological signals from the human heart; and wherein the method further comprises increasing a given confidence level at a given identified blocking location if an amplitude of an electrophysiological signal in proximity to the identified blocking location in the second set of electrophysiological signals is lower than an amplitude of an electrophysiological signal in the first set of electrophysiological signals. 2. The method according to claim 1 , wherein the recorded parameters comprise one or more of a power applied during the ablation, a length of time of the ablation, a force magnitude on a probe applying the ablation, and a temperature of tissue undergoing the ablation. 3. The method according to claim 2 , and wherein increasing the confidence levels as at least one of the power, the length of time, the force magnitude, and the temperature increases. 4. The method according to claim 1 , wherein identifying the blocking locations comprises inspecting an electrophysiological surface map generated in response to the first set of electrophysiological signals and the second set of electrophysiological signals. 5. The method according to claim 4 , wherein the electrophysiological surface map is configured to provide an indication of a re-entrant arrhythmia. 6. The method according to claim 1 , wherein the recorded parameters provide an assessment of the quality of the ablation based on at least one of a magnetic resonance imaging (MRI) image and an ultrasound image of the one or more ablation sites. 7. An apparatus, comprising: a screen; and a processor communicating with a memory and the screen, the processor configured to; before an ablation step, record a first set of electrophysiological signals at a plurality of first locations in a region of a human heart; during the ablation step, record parameters indicative of a quality of ablation performed at one or more ablation sites in the region of the human heart, after the ablation step, record a second set of electrophysiological signals indicative of a wave of electrical activation flowing through the region at a plurality of second locations in the region of the human heart, identify from a comparison of the first set of electrophysiological signals and the second set of electrophysiological signals a plurality of blocking locations within the region at which the wave is expected to be blocked from flowing by the ablation performed during the ablation step, for each identified blocking location within the region of the heart: estimate a first confidence level with respect to a blockage of the wave at the site by comparing an electrophysiological signal from the second set of electrophysiological signals with an electrophysiological signal in the first set of electrophysiological signals, where the electrophysiological signal from the first set and the electrophysiological signal from second set are recorded over a plurality of heart beats in proximity to the identified blocking location; estimate a second confidence level with respect to the blockage of the wave at the identified blocking location in response to the recorded parameters indicative of a quality of ablation; and determine an overall confidence level for each identified blocking location by combining the first confidence level and the second confidence level, the overall confidence level being an overall measure of the quality of the wave blocking of the ablation performed at the identified blocking location; and display a map of the human heart including the identified blocking location and an indication of the overall confidence level of that identified blocking location on the screen; wherein the first set of electrophysiological signals and the second set of electrophysiological signals are unstimulated electrophysiological signals from the human heart; and wherein the processor is further configured to increase a given confidence level at a given blocking location if an amplitude of an electrophysiological signal in proximity to an identified blocking location in the second set of electrophysiological signals is lower than an amplitude of an electrophysiological signal in the first set of electrophysiological signals. 8. The apparatus according to claim 7 , wherein the parameters comprise one or more of a power applied during the ablation, a length of time of the ablation, a force magnitude on a probe applying the ablation, and a temperature of tissue undergoing the ablation. 9. The apparatus according to claim 8 , and wherein increasing the confidence levels as at least one of the power, the length of time, the force magnitude, and the temperature increases. 10. The apparatus according to claim 7 , wherein the identified blocking locations are derived by inspecting an electrophysiological surface map generated in response to the first set of electrophysiological signals and the second set of electrophysiological signals. 11. The apparatus according to claim 10 , wherein the electrophysiological surface map is configured to provide an indication of a re-entrant arrhythmia. 12. The apparatus according to claim 7 , and comprising a probe configured to acquire the first set of electrophysiological signals and the second set of electrophysiological signals and to convey the first set of electrophysiological signals and the second set of electrophysiological signals to the processor. 13. The apparatus acco

Assignees

Inventors

Classifications

  • Invasive · CPC title

  • A61B5/367Primary

    Electrophysiological study [EPS], e.g. electrical activation mapping or electro-anatomical mapping · CPC title

  • A61B5/743Primary

    Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots · CPC title

  • for diagnosis of the heart · CPC title

  • Monitoring or testing the effects of treatment, e.g. of medication · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10980439B2 cover?
A method, including recording parameters indicative of a quality of ablation performed at one or more sites in a region of a human heart, and receiving a set of electrophysiological signals indicative of a wave of electrical activation flowing through the region. The method further includes identifying locations within the region at which the wave is blocked from flowing and estimating confiden…
Who is the assignee on this patent?
Biosense Webster Israel Ltd
What technology area does this patent fall under?
Primary CPC classification A61B5/367. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).